Martin Stockler describes this paper, which shows mixed effects of enza on QOL in prostate cancer.

Episode 166: Prostate cancer debate: doublet vs triplet first line therapy

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London